IL129383A0 - Method for producing an IgM preparation for intravenous administration - Google Patents

Method for producing an IgM preparation for intravenous administration

Info

Publication number
IL129383A0
IL129383A0 IL12938397A IL12938397A IL129383A0 IL 129383 A0 IL129383 A0 IL 129383A0 IL 12938397 A IL12938397 A IL 12938397A IL 12938397 A IL12938397 A IL 12938397A IL 129383 A0 IL129383 A0 IL 129383A0
Authority
IL
Israel
Prior art keywords
producing
intravenous administration
igm preparation
igm
preparation
Prior art date
Application number
IL12938397A
Other languages
English (en)
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of IL129383A0 publication Critical patent/IL129383A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL12938397A 1996-10-14 1997-10-14 Method for producing an IgM preparation for intravenous administration IL129383A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (1)

Publication Number Publication Date
IL129383A0 true IL129383A0 (en) 2000-02-17

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12938397A IL129383A0 (en) 1996-10-14 1997-10-14 Method for producing an IgM preparation for intravenous administration

Country Status (19)

Country Link
US (1) US6136312A (ru)
EP (1) EP0835880A1 (ru)
JP (1) JP2001504092A (ru)
KR (1) KR20000048826A (ru)
CN (1) CN1233258A (ru)
AU (1) AU725134B2 (ru)
BR (1) BR9712306A (ru)
CA (1) CA2266848A1 (ru)
CZ (1) CZ125599A3 (ru)
HU (1) HUP0001069A3 (ru)
ID (1) ID21364A (ru)
IL (1) IL129383A0 (ru)
NO (1) NO991733L (ru)
NZ (1) NZ334885A (ru)
PL (1) PL332774A1 (ru)
RU (1) RU2191032C2 (ru)
SI (1) SI9720063A (ru)
SK (1) SK46699A3 (ru)
WO (1) WO1998016558A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
JP5452835B2 (ja) 2003-07-15 2014-03-26 中外製薬株式会社 形質転換細胞によるIgMの産生とその定量方法
JP4671864B2 (ja) 2003-10-09 2011-04-20 中外製薬株式会社 タンパク質溶液の安定化方法
ATE518888T1 (de) * 2003-10-09 2011-08-15 Chugai Pharmaceutical Co Ltd Stabilisierte lösung mit hoher igm-konzentration
ES2409844T3 (es) * 2006-01-30 2013-06-28 Grifols Therapeutics Inc. Metodo para el tratamiento y la profilaxis de enfermedades relacionadas con la deposicion de amiloide utilizando IgM
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
WO2009140236A2 (en) * 2008-05-12 2009-11-19 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
CN106456763B (zh) 2014-06-03 2018-03-13 埃克斯生物科技公司 用于治疗和预防金黄色葡萄球菌感染的组合物和方法
EP4178978A1 (en) * 2020-07-10 2023-05-17 Grifols Worldwide Operations Limited Method for obtaining a composition comprising human plasma-derived immunoglobulin m

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (ru) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
AU725134B2 (en) 2000-10-05
CN1233258A (zh) 1999-10-27
RU2191032C2 (ru) 2002-10-20
PL332774A1 (en) 1999-10-11
KR20000048826A (ko) 2000-07-25
CZ125599A3 (cs) 1999-07-14
JP2001504092A (ja) 2001-03-27
WO1998016558A1 (de) 1998-04-23
HUP0001069A2 (hu) 2000-10-28
HUP0001069A3 (en) 2000-12-28
US6136312A (en) 2000-10-24
NO991733D0 (no) 1999-04-13
NZ334885A (en) 2000-09-29
AU4449597A (en) 1998-05-11
NO991733L (no) 1999-06-11
CA2266848A1 (en) 1998-04-23
ID21364A (id) 1999-05-27
EP0835880A1 (de) 1998-04-15
SK46699A3 (en) 2000-06-12
BR9712306A (pt) 1999-08-31
SI9720063A (sl) 1999-08-31

Similar Documents

Publication Publication Date Title
ZA962248B (en) Nanususpensions for intravenous administration
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
HU9203855D0 (en) An improved method for producing omeprazole
HU9700851D0 (en) Method for producing l-lysin
IL118689A0 (en) Intravenous infusion apparatus
HU9202172D0 (en) New n-benzoyl-amino-acid derivatives, medical preparatives containing said compounds and method for producing them
GB2298389B (en) Method for forming an armrest
HU9301404D0 (en) Method for preparing medical preparatives
HU9204011D0 (en) Method for producing benzo-quinazoline derivatives having medical effect
AU4012895A (en) Method for anesthetizing teeth
HUT64347A (en) Method for producing alkyl-diammonium-diclavulanate derivatives
HUP0001069A3 (en) Method for producing an igm preparation for intravenous administration
AU6184896A (en) Method for producing synthetic n-linked glycoconjugates
HU9301869D0 (en) New benzodiazepine derivatives, medical preparatives containing them and method for producing said compounds
PL307469A1 (en) Preparation for oral administration
HU9302108D0 (en) Method for producing physostigmine-carbamate derivatives
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
AU5347996A (en) Preparation for oral administration
IL130205A0 (en) Method for producing 1-phenyl-uracil derivatives
HU9302277D0 (en) Method for producing imidazo-pyridine derivatives
HUP9802942A3 (en) Method for preparing streptogramines
HU9203634D0 (en) Method for preparing medical preparatives having effect tot central nervous system containing nicotinyl-alanine
GB9509930D0 (en) Method for preparing certain acetonitriles
AU7910398A (en) Method for producing cyclic lactams
AU3746595A (en) Method for preparing poly-p-diisopropylbenzene